+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Third-party Pathology Diagnosis Center Market by Service Type, Technology, Application, End User, Sample Type, Delivery Mode - Global Forecast to 2030- Product Image
Third-party Pathology Diagnosis Center Market by Service Type, Technology, Application, End User, Sample Type, Delivery Mode - Global Forecast to 2030- Product Image
Sale

Third-party Pathology Diagnosis Center Market by Service Type, Technology, Application, End User, Sample Type, Delivery Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081035
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Third-party pathology diagnostics is rapidly transforming the delivery of laboratory services. As healthcare organizations prioritize precision medicine and operational agility, outsourcing pathology testing has become a core strategy for providers seeking specialized, timely, and scalable diagnostic solutions.

Market Snapshot: Pathology Diagnostics

The global market for third-party pathology diagnostics is expanding, driven by increased adoption of molecular and digital testing platforms. Industry growth is further supported by evolving clinical demands, growing emphasis on disease monitoring, and regulatory frameworks encouraging high-quality, cost-efficient care. Across regions, healthcare providers are increasingly leveraging external laboratory partners for a diverse range of routine and advanced assays, with demand particularly strong in oncology, neurology, and infectious disease applications.

Scope & Segmentation of Pathology Diagnostics

This report delivers an in-depth analysis of the dynamic third-party pathology diagnostics landscape. It covers a comprehensive range of segmentation factors to ensure decision-makers have the clarity required for strategic planning.

  • Service Types: Anatomic pathology, clinical pathology, cytogenetics, microbiology, molecular pathology (including fluorescence in situ hybridization, next generation sequencing such as targeted, whole exome, whole genome sequencing, and polymerase chain reaction)
  • Technologies: Digital pathology, flow cytometry, immunohistochemistry, next generation sequencing
  • Applications: Cardiology, gastroenterology, infectious diseases, neurology, oncology
  • End Users: Academic and research institutes, clinics, diagnostic laboratories, hospitals
  • Sample Types: Blood, tissue, urine
  • Delivery Modes: Inhouse and outsourced testing approaches
  • Regional Coverage: Americas (with focus on the United States, Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, and several others), and Asia-Pacific (prominently China, India, Japan, Australia, South Korea, Indonesia, Thailand, and more)
  • Key Companies Monitored: Quest Diagnostics Incorporated, Sonic Healthcare Limited, Eurofins Scientific SE, Synlab International GmbH, Unilabs SA, OPKO Health, Inc., SRL Diagnostics Private Limited, Cerba Healthcare SA, Fulgent Genetics, Inc.

Key Takeaways for Senior Decision-Makers

  • Third-party pathology centers play a critical role in extending specialized diagnostic capabilities to healthcare providers and research institutions lacking inhouse infrastructure.
  • Advanced technologies such as digital pathology and artificial intelligence streamline workflows and enable remote consultations, helping stakeholders achieve faster, more accurate diagnostic outcomes.
  • Service differentiation is increasingly reliant on the ability to provide molecular assays, high-throughput interpretation, and personalized diagnostic approaches tailored to complex clinical requirements.
  • Collaboration between laboratories and technology vendors is accelerating assay innovation and facilitating adaptation to emerging clinical and regulatory standards.
  • Operational success hinges on multidisciplinary team integration, robust validation protocols, and supply chain resilience built through domestic and international partnerships.
  • Competitive advantage is further secured by aligning testing portfolios with clinician expectations and payer requirements across diverse healthcare environments.

Tariff Impact on Pathology Diagnostics

Recent tariff measures in the United States have altered procurement strategies for pathology diagnostic providers. Elevated import costs for laboratory equipment and reagents have led to supply chain diversification and increased domestic production initiatives. Many laboratories are investing in localized reagent manufacturing and entering co-development agreements with vendors to manage price volatility and reduce dependence on international suppliers. These actions not only offset immediate cost challenges but also strengthen ecosystem resilience against future trade disruptions.

Methodology & Data Sources

This analysis is grounded in a rigorous research methodology featuring interviews with key industry stakeholders—including pathologists, laboratory directors, and regulatory experts—combined with extensive review of peer-reviewed publications, company reports, patent filings, and regulatory guidelines. Data triangulation and expert peer review ensure comprehensive, accurate, and actionable insights.

Why This Report Matters

  • Enables informed strategic planning by detailing evolving technology, service segments, and regional dynamics in pathology diagnostics.
  • Provides senior executives with actionable intelligence to guide investment decisions in response to regulatory shifts and market trends.
  • Supports operational agility and resilience by highlighting partnership, supply chain, and technology adoption best practices.

Conclusion

The third-party pathology diagnostics sector is experiencing rapid shifts, redefining clinical support paradigms. By leveraging the insights in this report, executives will be well positioned to navigate complexity, anticipate change, and drive sustainable growth in laboratory diagnostics.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Third-party Pathology Diagnosis Center Market, by Technology Used
8.1. Introduction
8.2. Automated Pathology
8.2.1. AI-Based Diagnostics
8.2.2. Robotic Systems
8.3. Digital Pathology
8.3.1. Digital Microscopy
8.3.2. Whole Slide Imaging
8.4. Web-Based Pathology Platform
8.4.1. Telepathology
9. Third-party Pathology Diagnosis Center Market, by Type Of Diagnosis
9.1. Introduction
9.2. Cytopathology
9.2.1. Fluid Cytology
9.2.2. Pap Smear Screening
9.3. Histopathology
9.3.1. Biopsy Analysis
9.3.2. Tissue Examination
9.4. Molecular Pathology
9.4.1. Biomarker Testing
9.4.2. Genetic Testing
10. Third-party Pathology Diagnosis Center Market, by End-User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Independent Labs
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research Institutes
10.4.1. Academic Research
10.4.2. Private Research Organizations
11. Third-party Pathology Diagnosis Center Market, by Application Areas
11.1. Introduction
11.2. Infectious Diseases
11.2.1. Bacterial Infections
11.2.2. Viral Infections
11.3. Neurology
11.3.1. Brain Disorders
11.3.2. Degenerative Diseases
11.4. Oncology
11.4.1. Cancer Screening
11.4.2. Tumor Classification
12. Third-party Pathology Diagnosis Center Market, by Payment And Service Model
12.1. Introduction
12.2. Fee-For-Service
12.2.1. Per Test Fee
12.3. Package Deals
12.3.1. Volume Discounts
12.4. Subscription-Based Model
12.4.1. Monthly Subscription
13. Third-party Pathology Diagnosis Center Market, by Patient Demographics
13.1. Introduction
13.2. Age Group
13.2.1. Adult
13.2.2. Geriatric
13.2.3. Pediatric
13.3. Gender
13.3.1. Female
13.3.2. Male
13.3.3. Non-Binary
13.4. Lifestyle Factors
13.4.1. Non-Smokers
13.4.2. Smokers
14. Third-party Pathology Diagnosis Center Market, by Laboratory Equipment
14.1. Introduction
14.2. Data Analysis Tools
14.2.1. Cloud-Based Analytics
14.2.2. Software Platforms
14.3. Imaging Systems
14.3.1. Microscopes
14.3.2. Spectrometers
14.4. Staining Devices
14.4.1. Automated Stainers
14.4.2. Manual Stainers
15. Americas Third-party Pathology Diagnosis Center Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Third-party Pathology Diagnosis Center Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Third-party Pathology Diagnosis Center Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. ACM Global Laboratories
18.3.2. ARUP Laboratories
18.3.3. Bio-Reference Laboratories, Inc.
18.3.4. Charles River Laboratories International, Inc.
18.3.5. Eurofins Scientific
18.3.6. Foundation Medicine, Inc.
18.3.7. Fulgent Genetics
18.3.8. Genomic Health, Inc.
18.3.9. Guardant Health, Inc.
18.3.10. LabCorp (Laboratory Corporation of America Holdings)
18.3.11. Myriad Genetics, Inc.
18.3.12. NeoGenomics Laboratories
18.3.13. Quest Diagnostics Incorporated
18.3.14. Sonic Healthcare Limited
18.3.15. Unilabs Group Services
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET MULTI-CURRENCY
FIGURE 2. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET MULTI-LANGUAGE
FIGURE 3. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2024 VS 2030 (%)
FIGURE 20. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AI-BASED DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE SLIDE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TELEPATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUID CYTOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAP SMEAR SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BIOPSY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE EXAMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PRIVATE RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BRAIN DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TUMOR CLASSIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PER TEST FEE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY VOLUME DISCOUNTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MONTHLY SUBSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NON-BINARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NON-SMOKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SMOKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SOFTWARE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED STAINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MANUAL STAINERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 180. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 181. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 182. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 183. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 185. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 186. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 187. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 189. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 192. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 193. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 194. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 195. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 196. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 197. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 198. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 199. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 200. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 202. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 203. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 204. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 205. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 207. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 208. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 209. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 210. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 211. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 212. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 213. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 214. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 215. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 217. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 219. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 221. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 222. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 223. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 224. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 225. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 226. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 227. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 228. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 229. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 230. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 231. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 232. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 233. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 234. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 250. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 251. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PAYMENT AND SERVICE MODEL, 2018-2030 (USD MILLION)
TABLE 252. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FEE-FOR-SERVICE, 2018-2030 (USD MILLION)
TABLE 253. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PACKAGE DEALS, 2018-2030 (USD MILLION)
TABLE 254. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SUBSCRIPTION-BASED MODEL, 2018-2030 (USD MILLION)
TABLE 255. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 256. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 258. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LIFESTYLE FACTORS, 2018-2030 (USD MILLION)
TABLE 259. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY LABORATORY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 260. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DATA ANALYSIS TOOLS, 2018-2030 (USD MILLION)
TABLE 261. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMAGING SYSTEMS, 2018-2030 (USD MILLION)
TABLE 262. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STAINING DEVICES, 2018-2030 (USD MILLION)
TABLE 263. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY USED, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY AUTOMATED PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WEB-BASED PATHOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TYPE OF DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HISTOPATHOLOGY, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION AREAS, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Third-party Pathology Diagnosis Center market report include:
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Eurofins Scientific SE
  • Synlab International GmbH
  • Unilabs SA
  • OPKO Health, Inc.
  • SRL Diagnostics Private Limited
  • Cerba Healthcare SA
  • Fulgent Genetics, Inc.

Related Topics

Related Reports

Third-party Health Check-up Center Market by Service Type, Package Type, Customer Type, Booking Mode, Payment Mode, Test Type, Age Group, Gender - Global Forecast to 2030 - Product Image

Third-party Health Check-up Center Market by Service Type, Package Type, Customer Type, Booking Mode, Payment Mode, Test Type, Age Group, Gender - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Regional Outlook and Forecast, 2025 - 2032 - Product Image

Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Regional Outlook and Forecast, 2025 - 2032

  • Report
  • 352 Pages
  • Global
From
Artificial Intelligence in Healthcare Diagnosis Market Report 2025 - Product Image

Artificial Intelligence in Healthcare Diagnosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Healthcare Third-party Logistics Market by Temperature, Distribution Channel, Healthcare Type, Transportation Mode, End User, Service Type - Global Forecast to 2030 - Product Image

Healthcare Third-party Logistics Market by Temperature, Distribution Channel, Healthcare Type, Transportation Mode, End User, Service Type - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
UCaaS in Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

UCaaS in Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.